Cargando…

Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers

BACKGROUND & OBJECTIVE: Breast cancer is one of the most common cancers in the world. There are some different types of breast cancer and triple-negative breast cancer is the type in which no receptors for estrogen, progesterone, and human epidermal growth factor receptor-2 are expressed. Identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahadi, Mahsa, Moradi, Afshin, Rabiee, Elham, Pourmotahari, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293598/ https://www.ncbi.nlm.nih.gov/pubmed/37383162 http://dx.doi.org/10.30699/IJP.2023.561917.2969

Ejemplares similares

Comparison of GATA-3, Mammaglobin and GCDFP-15 Expression in Primary, Metastatic and Triple Negative Breast Carcinomas: An Indian Scenario
por: Rao, Meenakshi, et al.
Publicado: (2023)

Immunoexpression of the GCDFP-15 Marker in Different Grades of Breast Carcinoma
por: Shirian, Faeze, et al.
Publicado: (2023)

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
por: Darb-Esfahani, Silvia, et al.
Publicado: (2014)

Gross Cystic Disease Fluid Protein-15 (GCDFP-15) Expression Characterizes Breast Mucinous Carcinomas in Older Women
por: Kinoshita, Mayumi, et al.
Publicado: (2022)

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2013)

Androgen receptor increases and negative expression of GCDFP-15 in primary ductal adenocarcinoma of the lacrimal gland: a case description
por: Yang, Shideng, et al.
Publicado: (2023)

Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren’s Syndrome
por: Gallo, A, et al.
Publicado: (2013)

GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review
por: Zhu, Miao-Miao, et al.
Publicado: (2015)

The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
por: Ahadi, Mahsa, et al.
Publicado: (2020)

Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
por: Darbeheshti, Farzaneh, et al.
Publicado: (2021)

GATA3 Inhibits Lysyl Oxidase Mediated Metastases of Human Basal Triple-Negative Breast Cancer Cells
por: Chu, Isabel M., et al.
Publicado: (2011)

Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß
por: Chu, Isabel M., et al.
Publicado: (2013)

LncRNA GATA3‐AS1 facilitates tumour progression and immune escape in triple‐negative breast cancer through destabilization of GATA3 but stabilization of PD‐L1
por: Zhang, Ming, et al.
Publicado: (2020)

Quantity and Distribution of Eosinophils in Esophageal Specimens of Adults: An Iranian Population-Based Study
por: Jamali, Elena, et al.
Publicado: (2022)

Evaluation of P53 and CK20 Immunohistochemical Markers in Comparison with Morphologic Findings in Low- and High-grade Urothelial Carcinomas
por: Ahadi, Mahsa, et al.
Publicado: (2021)

Unusual Gastric Metastasis in Triple-Negative (Estrogen Receptor/Progesterone Receptor/HER2neu Negative) GATA-Binding Protein 3-Positive Breast Cancer
por: Baa, Annie Kanchan, et al.
Publicado: (2020)

Basic Characteristics of Oligodendrogliomas at the Shohada-e Tajrish Hospital (2008 to 2014)
por: Ahadi, Mahsa, et al.
Publicado: (2017)

A Comparison between the Diagnostic Accuracy of Frozen Section and Permanent Section Analyses in Central Nervous System
por: Amraei, Razie, et al.
Publicado: (2017)

Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer
por: Mugisha, Samson, et al.
Publicado: (2022)

High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method
por: Naimi, Azar, et al.
Publicado: (2022)

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
por: Albergaria, André, et al.
Publicado: (2009)

GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation
por: Oda, Husam, et al.
Publicado: (2023)

Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
por: De-la-Cruz-Ku, Gabriel, et al.
Publicado: (2020)

GATA4 negatively regulates bone sialoprotein expression in osteoblasts
por: Song, Insun, et al.
Publicado: (2016)

Interobserver Agreement in Assessing Dysplasia in Colorectal Adenomatous Polyps: A Multicentric Iranian Study
por: Mollasharifi, Tahmineh, et al.
Publicado: (2020)

Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment
por: Keihan Shokooh, Mahsa, et al.
Publicado: (2021)

Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple‐negative breast cancer
por: Zhang, Danfang, et al.
Publicado: (2020)

Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance
por: Lu, Shaolei, et al.
Publicado: (2019)

Hemangioblastoma of the Central Nervous System: A Case Series of Patients Surgically Treated at Shohada-e-Tajrish Hospital, Tehran, Iran during 2004-2014
por: AHADI, Mahsa, et al.
Publicado: (2019)

Androgen Receptor Expression and Its Correlation with Clinicopathological Parameters in Iranian Patients with Triple Negative Breast Cancer
por: Naimi, Azar, et al.
Publicado: (2020)

SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation
por: Gao, Yongchang, et al.
Publicado: (2022)

GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
por: Yang, Naery, et al.
Publicado: (2018)

LAG-3 expression in tumor microenvironment of triple-negative breast cancer
por: TAHTACI, Gözde, et al.
Publicado: (2022)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
por: Darb-Esfahani, S, et al.
Publicado: (2012)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

An Investigation on the Results of Cytopathologic Tests of Pancreatobiliary System Performed in the Pathology Department in Iran
por: Moradi, Afshin, et al.
Publicado: (2021)

Significance of E-cadherin expression in triple-negative breast cancer
por: Kashiwagi, S, et al.
Publicado: (2010)

Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
por: Hessel, Harald, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bn0t5msjvf41gk8k1jvag8lhek